Sign In
Buy GLTO
$22.20
+0 (+0%)
At Close: Jun 18, 2026
Galecto stock skyrockets 600%: why tiny float stocks are market's latest gamble
10:27am, Tuesday, 07'th Oct 2025
Galecto stock (NASDAQ: GLTO) went absolutely bonkers on Tuesday, surging over 600% in what might be one of the wildest rallies we have seen from a small biotech in recent memory. The shares jumped fro
Galecto Reports Second Quarter 2025 Operating and Financial Results
04:15pm, Tuesday, 05'th Aug 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced
12,701 Shares in Galecto, Inc. (NASDAQ:GLTO) Bought by Squarepoint Ops LLC
03:34am, Wednesday, 11'th Jun 2025
Squarepoint Ops LLC bought a new position in shares of Galecto, Inc. (NASDAQ:GLTO – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and
Galecto Reports First Quarter 2025 Operating and Financial Results
04:30pm, Thursday, 08'th May 2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced
Galecto Reports Full-Year 2024 Financial Results
04:45pm, Wednesday, 19'th Mar 2025
BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced
Galecto to Participate in Upcoming Investor Conferences
08:00am, Thursday, 06'th Feb 2025
BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and severe liver diseases, toda
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Thursday, 14'th Nov 2024
Galecto (GLTO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre
Galecto Reports Third Quarter 2024 Financial Results
08:30am, Friday, 01'st Nov 2024
- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420, a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets o
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
08:30am, Tuesday, 15'th Oct 2024
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced t
BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced t
Galecto Announces Reverse Stock Split
09:00am, Wednesday, 28'th Aug 2024
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced t
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
04:01pm, Wednesday, 01'st May 2024
An NCI-supported Phase 2 investigator-initiated trial at the Providence Cancer Institute in Portland, Oregon, has enrolled its first patient in a study exploring the combination of pembrolizumab (Keyt
Galecto, Inc. (GLTO) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 14'th Feb 2024
Galecto, Inc. (GLTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for February 14th
06:50am, Wednesday, 14'th Feb 2024
GLTO, LUMN, MORF, SFST and STOK have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
What Makes Galecto, Inc. (GLTO) a New Strong Buy Stock
06:02pm, Tuesday, 09'th Jan 2024
Galecto, Inc. (GLTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
